PYRIMIDINE-SUBSTITUTED PURINE COMPOUNDS AS KINASE(S) INHIBITORS Russian patent published in 2014 - IPC C07D473/32 A61K31/52 A61P35/00 

Abstract RU 2506264 C2

FIELD: chemistry.

SUBSTANCE: claimed invention relates to novel pyrimidine-substituted purine compound of formula (I) or pharmaceutically acceptable salt of said compound, which possess inhibiting action with respect to mTOR and P13 kinases and can be applied in cancer treatment. Formula (I) compound corresponds to structural formula Formula (I)

EFFECT: invention relates to pharmaceutical composition which contains therapeutically effective quantity of said compound and pharmaceutically acceptable diluents, auxiliary substance or carrier, to method of inhibition of proteinkinase, selected from mTOR or P13 kinase, and to method of treatment or prevention of state in mammal, associated with inhibition of mTOR and/or P13 kinase activity.

11 cl, 1 tbl, 3 ex

Similar patents RU2506264C2

Title Year Author Number
PYRIMIDINE-SUBSTITUTED PURINE DERIVATIVES, PHARMACEUTICAL COMPOSITION BASED THEREON, METHOD OF PROTEIN KINASE INHIBITION, METHOD OF TREATING OR PREVENTING DISEASES SENSITIVE TO PROTEIN KINASE INHIBITION AND METHOD OF TREATING PROLIFERATIVE DISEASES 2008
  • Nagaradzh Kharish Kumar Majsur
  • Uil'Jams Meredit
RU2518098C2
PYRIMIDINE-SUBSTITUTED DERIVATIVES OF PURINE, PHARMACEUTICAL COMPOSITION BASED THEREON, METHOD FOR INHIBITING PROTEIN KINASE, METHOD FOR TREATMENT OR PREVENTION OF DISEASES SUSCEPTIBLE TO INHIBITING PROTEIN KINASE, AND METHOD OF TREATING PROLIFERATIVE DISEASES 2008
  • Nagaradzh Kharish Kumar Majsur
  • Uilyams Meredit
RU2681081C2
COMBINATION OF PHOSPHATIDYL INOSITOL-3-KINASE (PI3K) INHIBITOR AND mTOR INHIBITOR 2009
  • Karlos Garsija-Ehcheverrija
  • Sove-Mishel' Maira
RU2538683C2
SOME CHEMICAL COMPOUNDS, COMPOSITIONS AND METHODS 2010
  • Ren Pingda
  • Liu Ji
  • Uilson Troj Edvard
  • Li Liansheng
  • Chan Katrina
  • Rommel Kristian
RU2582676C2
CHEMICAL COMPOUNDS, COMPOSITIONS AND METHODS 2010
  • Ren Pingda
  • Liu Yi
  • Wilson Troy Edward
  • Li Liansheng
  • Chan Katrina
  • Rommel Christian
RU2746319C2
MORPHOLINO-SUBSTITUTED DERIVATIVES OF UREA OR CARBAMATE AS MTOR INHIBITORS 2012
  • Lynch Rosemary
  • Cansfield Andrew David
  • Hardy Daniel Paul
  • Sunose Mihiro
  • Morel Adeline
  • Convery Laura
  • Adrego Rita
RU2616619C2
HYDROXYLATED PYRIMIDYLCYCLOPENTANES AS PROTEIN KINASE (AKT) INHIBITORS 2009
  • Benksik Jozef R.
  • Blehjk Dzhejms F.
  • Kallan Nikolas K.
  • Mitchell Jan S.
  • Spenser Kit Li
  • Ksiao Dengming
  • Ksu Rui
  • Chabot Kristin
  • Do Stiven
  • Liang Dzun
  • Safina Brajan
  • Chzhang Birong
RU2504542C2
COMPOSITIONS, CONTAINING (S)-2-AMINO-1-(4-CHLOROPHENYL)-1-[4-(1H-PYRAZOL-4-YL)PHENYL]ETHANOL AS MODULATORS OF PROTEINKINASES 2008
  • Stiven Dzhon Vudkhed
  • Dejvid Charlz Ris
  • Martin Frederikson
  • Kajla Merriom Grimsho
RU2527151C2
TREATING NEUROENDOCRINE TUMOURS 2006
  • Marks Piter Uehjn
  • Lebuol' Dejvid
RU2487711C2
COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS 2006
  • Rehn' Pinda
  • Grej Natanaehl S.
  • Van Sja
  • Chzhan Guobao
RU2383545C2

RU 2 506 264 C2

Authors

Chehn' Dichzhun

Vil'Jams Meredit

Dates

2014-02-10Published

2009-04-03Filed